IMN || Journal

Prostate cancer surveillance appears safe through 15 years

Posted on: 15/12/2014 - 21:00

Active surveillance appears to be safe through 15 years of follow-up for men who have low-risk prostate cancer, according to a report published online Dec. 15 in the Journal of Clinical Oncology. In...

Field of Interest: Oncology
Type: News Item

AI-induced symptoms don’t predict survival

Posted on: 15/12/2014 - 21:00

Vasomotor and musculoskeletal symptoms associated with aromatase inhibitor adjuvant therapy do not signal a more intense treatment response and thus do not predict better survival in women with...

Field of Interest: Oncology
Type: News Item

AI-induced symptoms don’t predict survival

Posted on: 15/12/2014 - 21:00

Vasomotor and musculoskeletal symptoms associated with aromatase inhibitor adjuvant therapy do not signal a more intense treatment response and thus do not predict better survival in women with...

Field of Interest: Pulmonology
Type: News Item

No increase in prostate cancer with testosterone therapy

Posted on: 05/12/2014 - 13:36

A study of hypogonadal men undergoing testosterone therapy has found a lower rate of prostate cancer than previously recorded in screening studies, suggesting the therapy does not increase prostate...

Field of Interest: Oncology
Type: News Item

Statins don’t cut fracture risk

Posted on: 01/12/2014 - 21:00

Daily rosuvastatin did not decrease fracture risk in a large international clinical trial involving older men and women who had elevated CRP levels, according to a report published online Dec. 1 in...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness